Storia in 2 fonti

Exclusive: Treasury is assessing options to screen investments in China biotech

Treasury weighs adding biotech to outbound investment screening rules, a move that could chill or block US deals with China biotechs.

Raccontata da

Confronto fonti

2 prospettive sulla stessa storia

AI · summaries

endpoints.newsStai leggendo1 mese fa

Treasury weighs adding biotech to outbound investment screening rules, a move that could chill or block US deals with China biotechs.

US lawmakers push Treasury to screen outbound biotech investments in China under the COINS Act. BINSA bill targets pharmaceutical IP and drug deals.